DeSantis C.E. Ma J. Gaudet M.M. et al.

Breast cancer statistics, 2019.

CA: a Cancer J clinicians. 69: 438-451Committee on Cancer Survivorship: improving care and quality of life, Institute of medicine and national research council. From cancer patient to cancer survivor: lost in transition. National Academy of Sciences, Washington, DCNeuman H.B. Steffens N.M. Jacobson N. et al.

Oncologists' Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up.

Ann Surg Oncol. 23: 708-714Tucholka J.L. Jacobson N. Steffens N.M. et al.

Breast cancer survivor's perspectives on the role different providers play in follow-up care.

Support Care Cancer. 26: 2015-2022McGinty H.L. Small B.J. Laronga C. et al.

Predictors and patterns of fear of cancer recurrence in breast cancer survivors.

Health Psychol. 35: 1-9Stark D. Kiely M. Smith A. et al.

Reassurance and the anxious cancer patient.

Br J Cancer. 91: 893-899Yang W. Williams J.H. Hogan P.F. et al.

Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage.

J Oncol Pract/Am Soc Clin Oncol. 10: 39-45The complexities of physician supply and demand: projections from 2018-2033. Association of American Medical Colleges, Washington, DCKhatcheressian J.L. Hurley P. Bantug E. et al.

Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.

J Clin Oncol. 31: 961-965National Comprehensive Cancer Network

National comprehensive cancer Network clinical practice guidelines in oncology: breast cancer.

() ()Runowicz C.D. Leach C.R. Henry N.L. et al.

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

J Clin Oncol. 34: 611-635Saphner T. Tormey D.C. Gray R.

Annual hazard rates of recurrence for breast cancer after primary therapy.

J Clin Oncol. 14: 2738-2746Giuliano A.E. Edge S.B. Hortobagyi G.N.

Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer.

Ann Surg Oncol. 25: 1783-1785Weiss A. Chavez-MacGregor M. Lichtensztajn D.Y. et al.

Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer.

JAMA Oncol. 4: 203-209Plichta J.K. Ren Y. Thomas S.M. et al.

Implications for Breast Cancer Restaging Based on the 8th Edition AJCC Staging Manual.

Ann Surg. 271: 169-176Colleoni M. Sun Z. Price K.N. et al.

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.

J Clin Oncol. 34: 927-935Pan H. Gray R. Braybrooke J. et al.

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

N Engl J Med. 377: 1836-1846Neuman H.B. Weiss J.M. Schrag D. et al.

Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors.

Ann Surg Oncol. 20: 4128-4136Ganz P.A. Hahn E.E. Petersen L. et al.

Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena).

Clin Breast Cancer. 16: 356-363

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial.

JAMA. 271: 1587-1592Rosselli Del Turco M. Palli D. Cariddi A. et al.

Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer Follow-Up.

JAMA. 271: 1593-1597Rojas M.P. Telaro E. Russo A. et al.

Follow-up strategies for women treated for early breast cancer.

Cochrane Database Syst Rev. : CD001768Schumacher J.R. Neuman H.B. Yu M. et al.

Surveillance imaging vs symptomatic recurrence detection and survival in stage II-III breast cancer (AFT-01).

J Natl Cancer Inst. https://doi.org/10.1093/jnci/djac131Grunfeld E. Hodgson D.C. Del Giudice M.E. et al.

Population-based longitudinal study of follow-up care for breast cancer survivors.

J Oncol Pract/Am Soc Clin Oncol. 6: 174-181Panageas K.S. Sima C.S. Liberman L. et al.

Use of high technology imaging for surveillance of early stage breast cancer.

Breast Cancer Res Treat. 131: 663-670Hahn E.E. Hays R.D. Kahn K.L. et al.

Use of Imaging and Biomarker Tests for Posttreatment Care of Early-Stage Breast Cancer Survivors.

Cancer-am Cancer Soc. 119: 4316-4324Geurts S.M. de Vegt F. Siesling S. et al.

Pattern of follow-up care and early relapse detection in breast cancer patients.

Breast Cancer Research Treat. 136: 859-868Schumacher J.R. Neuman H.B. Chang G.J. et al.

A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).

Ann Surg Oncol. 25: 2587-2595American Board of Internal Medicine Foundation

Choosing wisely clinician lists.

() ()McNaul D. Darke M. Garg M. et al.

An evaluation of post-lumpectomy recurrence rates: is follow-up every 6 months for 2 years needed?.

J Surg Oncol. 107: 597-601Haas C.B. Nekhlyudov L. Lee J.M. et al.

Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis.

Breast Cancer Res Treat. 181: 255-268

Wernli K, Brandzel S, Buist D, et al. In: Is Breast MRI Better at Finding Second Breast Cancers than Mammograms Alone for Breast Cancer Survivors? Washington (DC)2019.

Saslow D. Boetes C. Burke W. et al.

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.

CA: a Cancer J Clinicians. 57: 75-89Bouchardy C. Benhamou S. Fioretta G. et al.

Risk of second breast cancer according to estrogen receptor status and family history.

Breast Cancer Res Treat. 127: 233-241Kurian A.W. McClure L.A. John E.M. et al.

Second primary breast cancer occurrence according to hormone receptor status.

J Natl Cancer Inst. 101: 1058-1065Fowble B. Hanlon A. Freedman G. et al.

Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.

Int J Radiat Oncol Biol Phys. 51: 679-690Strigel R.M. Bravo E. Tevaarwerk A.J. et al.

Development and Implementation of an Algorithm to Guide MRI Screening in Patients With a Personal History of Treated Breast Cancer.

Clin Breast Cancer. 21: 26-30Yang T.J. Yang Q. Haffty B.G. et al.

Prognosis for mammographically occult, early-stage breast cancer patients treated with breast-conservation therapy.

Int J Radiat Oncol Biol Phys. 76: 79-84Boyd N.F. Guo H. Martin L.J. et al.

Mammographic density and the risk and detection of breast cancer.

N Engl J Med. 356: 227-236Zakhireh J. Fowble B. Esserman L.J.

Application of screening principles to the reconstructed breast.

J Clin Oncol. 28: 173-180Neuman H.B. Steffens N. Tevaarwerk A.J. et al.

Oncologists’ priorities for breast cancer follow-up.

Am Soc Clin Oncol. Partridge A.H. LaFountain A. Mayer E. et al.

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.

J Clin Oncol. 26: 556-562Nekhlyudov L. Li L. Ross-Degnan D. et al.

Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.

Breast Cancer Res Treat. 130: 681-689Hershman D.L. Kushi L.H. Shao T. et al.

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.

J Clin Oncol. 28: 4120-4128Ruddy K. Mayer E. Partridge A.

Patient adherence and persistence with oral anticancer treatment.

CA Cancer J Clin. 59: 56-66

Sticking to It: Improving Outcomes by Increasing Adherence.

J Clin Oncol. 34: 2440-2442Henry N.L. Azzouz F. Desta Z. et al.

Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer.

J Clin Oncol. 30: 936-942Chim K. Xie S.X. Stricker C.T. et al.

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.

BMC Cancer. 13: 401Mustafa Ali M. Moeller M. Rybicki L. et al.

Prevalence and correlates of patient-reported symptoms and comorbidities in breast cancer survivors at a tertiary center.

J Cancer Survivorship : Res Pract. 11: 743-750de Ligt K.M. Heins M. Verloop J. et al.

Patient-reported health problems and healthcare use after treatment for early-stage breast cancer.

Breast. 46: 4-11Kurian A.W. Bondarenko I. Jagsi R. et al.

Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.

J Natl Cancer Inst. 110: 493-500Dinan M.A. Mi X. Reed S.D. et al.

Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.

JAMA Oncol. 1: 1098-1109Schumacher J.R. Taylor L.J. Tucholka J.L. et al.

Socioeconomic Factors Associated with Post-Mastectomy Immediate Reconstruction in a Contemporary Cohort of Breast Cancer Survivors.

Ann Surg Oncol. 24: 3017-3023Jonczyk M.M. Jean J. Graham R. et al.

Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis.

Breast Cancer Res Treat. 173: 267-274Boughey J.C. Suman V.J. Mittendorf E.A. et al.

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

JAMA. 310: 1455-1461Krag D.N. Anderson S.J. Julian T.B. et al.

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Lancet Oncol. 11: 927-933Lucci A. McCall L.M. Beitsch P.D. et al.

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

J Clin Oncol. 25: 3657-3663Wilke L.G. McCall L.M. Posther K.E. et al.

Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.

Ann Surg Oncol. 13: 491-500Whelan T.J. Olivotto I.A. Parulekar W.R. et al.

Regional Nodal Irradiation in Early-Stage Breast Cancer.

N Engl J Med. 373: 307-316Donker M. van Tienhoven G. Straver M.E. et al.

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Lancet Oncol. 15: 1303-1310McLaughlin S.A. Staley A.C. Vicini F. et al.

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions.

Ann Surg Oncol. 24: 2818-2826Chang D.W. Dayan J. Greene A.K. et al.

Surgical Treatment of Lymphedema: A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference.

Plast Reconstr Surg. 147: 975-993Ferguson C.M. Swaroop M.N. Horick N. et al.

Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer.

J Clin Oncol. 34: 691-698Asdourian M.S. Skolny M.N. Brunelle C. et al.

Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis.

Lancet Oncol. 17: e392-e405Schmitz K.H. Troxel A.B. Dean L.T. et al.

Effect of Home-Based Exercise and Weight Loss Programs on Breast Cancer-Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER Survivor Randomized Clinical Trial.

JAMA Oncol. 5: 1605-1613Schmitz K.H. Ahmed R.L. Troxel A.B. et al.

Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial.

JAMA. 304: 2699-2705Soldera S.V. Ennis M. Lohmann A.E. et al.

Sexual health in long-term breast cancer survivors.

Breast Cancer Res Treat. 172: 159-166Gass J.S. Onstad M. Pesek S. et al.

Breast-Specific Sensuality and Sexual Function in Cancer Survivorship: Does Surgical Modality Matter?.

Ann Surg Oncol. 24: 3133-3140Flynn K.E. Reese J.B. Jeffery D.D. et al.

Patient experiences with communication about sex during and after treatment for cancer.

Psychooncology. 21: 594-601Simard S. Thewes B. Humphris G. et al.

Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies.

J Cancer Survivorship : Res Pract. 7: 300-322Harris J. Cornelius V. Ream E. et al.

Anxiety after completion of treatment for early-stage breast cancer: a systematic review to identify candidate predictors and evaluate multivariable model development.

Support Care Cancer. 25: 2321-2333Zainal N.Z. Nik-Jaafar N.R. Baharudin A. et al.

Prevalence of depression in breast cancer survivors: a systematic review of observational studies.

Asian Pac J Cancer Prev. 14: 2649-2656Kroenke K. Spitzer R.L. Williams J.B.

The Patient Health Questionnaire-2: validity of a two-item depression screener.

Med Care. 41: 1284-1292Spitzer R.L. Kroenke K. Williams J.B. et al.

A brief measure for assessing generalized anxiety disorder: the GAD-7.

Arch Intern Med. 166: 1092-1097Coughlin S.S. Ayyala D.N. Tingen M.S. et al.

Financial distress among breast cancer survivors.

Curr Cancer Rep. 2: 48-53Jagsi R. Pottow J.A. Griffith K.A. et al.

Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.

J Clin Oncol. 32: 1269-1276Dean L.T. Moss S.L. Ransome Y. et al.

It still affects our economic situation": long-term economic burden of breast cancer and lymphedema.

Support Care Cancer. 27: 1697-1708Colzani E. Liljegren A. Johansson A.L. et al.

Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics.

J Clin Oncol. 29: 4014-4021Patnaik J.L. Byers T. Diguiseppi C. et al.

The influence of comorbidities on overall survival among older women diagnosed with breast cancer.

J Natl Cancer Inst. 103: 1101-1111Ramin C. Schaeffer M.L. Zheng Z. et al.

All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.

J Natl Cancer Inst. 113: 137-145Arora N.K. Reeve B.B. Hays R.D. et al.

Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective.

J Clin Oncol. 29: 1280-1289Siembida E.J. Kent E.E. Bellizzi K.M. et al.

Healthcare providers' discussions of physical activity with older survivors of cancer: Potential missed opportunities for health promotion.

J Geriatr Oncol. 11: 437-443Rai A. Chawla N. Han X. et al.

Has the Quality of Patient-Provider Communication About Survivorship Care Improved?.

J Oncol Pract/Am Soc Clin Oncol. 15: e916-e924Jiralerspong S. Goodwin P.J.

Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities.

J Clin Oncol. 34: 4203-4216Rock C.L. Thomson C. Gansler T. et al.

American Cancer Society guideline for diet and physical activity for cancer prevention.

CA: a Cancer J Clinicians. 70: 245-271

Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis.

Ann Oncol. 25: 1293-1311LoConte N.K. Brewster A.M. Kaur J.S. et al.

Alcohol and Cancer: A Statement of the American Society of Clinical Oncology.

J Clin Oncol. 36: 83-93Simapivapan P. Boltong A. Hodge A.

To what extent is alcohol consumption associated with breast cancer recurrence and second primary breast cancer?: A systematic review.

Cancer Treat Rev. 50: 155-167Halpern M.T. Viswanathan M. Evans T.S. et al.

Models of Cancer Survivorship Care: Overview and Summary of Current Evidence.

J Oncol Pract/Am Soc Clin Oncol. 11: e19-e27Oeffinger K.C. McCabe M.S.

Models for delivering survivorship care.

J Clin Oncol. 24: 5117-5124Miller K.D. Pandey M. Jain R. et al.

Cancer Survivorship and Models of Survivorship Care: A Review.

Am J Clin Oncol. 38: 627-633Grunfeld E. Levine M.N. Julian J.A. et al.

Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care.

J Clin Oncol. 24: 848-855

From cancer patient to cancer survivor: lost in transition.

National Academy Press, Washington, DCAmerican College of Surgeons Commission on Cancer () ()Grunfeld E. Julian J.A. Pond G. et al.

Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer.

J Clin Oncol. 29: 4755-4762Hershman D.L. Greenlee H. Awad D. et al.

Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors.

Breast Cancer Res Treat. 138: 795-806Joshi A. Larkins S. Evans R. et al.

Use and impact of breast cancer survivorship care plans: a systematic review.

Breast Cancer. 28: 1292-1317Jacobsen P.B. DeRosa A.P. Henderson T.O. et al.

Systematic Review of the Impact of Cancer Survivorship Care Plans on Health Outcomes and Health Care Delivery.

J Clin Oncol. 36: 2088-2100Birken S.A. Raskin S. Zhang Y. et al.

Survivorship Care Plan Implementation in US Cancer Programs: a National Survey of Cancer Care Providers.

J Cancer Educ. 34: 614-622Klemanski D.L. Browning K.K. Kue J.

Survivorship care plan preferences of cancer survivors and health care providers: a systematic review and quality appraisal of the evidence.

J Cancer Survivorship : Res Pract. 10: 71-86Rosselli Del Turco M. Palli D. Cariddi A. et al.

Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up.

JAMA. 271: 1593-1597